MAPK3 Gene - ERK1

MAPK3 Gene

Pathway Diagram

```mermaid
flowchart TD
MAPK3["MAPK3"]
style MAPK3 fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0
Mapk["Mapk"]
MAPK3 -->|"therapeutic target"| Mapk
Neurodegeneration["Neurodegeneration"]
MAPK3 -->|"involved in"| Neurodegeneration
Endoplasmic_Reticulum_Stress_R["Endoplasmic Reticulum Stress Response"]
MAPK3 -->|"mediates"| Endoplasmic_Reticulum_Stress_R
Apoptosis["Apoptosis"]
MAPK3 -->|"involved in"| Apoptosis
Cancer_Related_Signal_Transduc["Cancer-Related Signal Transduction"]
MAPK3 -->|"involved in"| Cancer_Related_Signal_Transduc
Atherosclerosis["Atherosclerosis"]
MAPK3 -->|"associated with"| Atherosclerosis
GENES["GENES"]
MAPK3 -->|"therapeutic target"| GENES
MAPK3 -->|"therapeutic target"| Apoptosis
Ros["Ros"]
Ros -->|"activates"| MAPK3
KDEL["KDEL"]
KDEL -->|"activates"| MAPK3
Cholix["Cholix"]
Cholix -->|"upregulates"| MAPK3
Shexiang_Baoxin_Pill["Shexiang Baoxin Pill"]
Shexiang_Baoxin_Pill -->|"downregulates"| MAPK3
PRKCD["PRKCD"]
PRKCD -->|"associated with"| MAPK3
style Mapk fill:#5d4400,stroke:#4fc3f7,color:#e0e0e0
style Neurodegeneration fill:#888,stroke:#4fc3f7,color:#e0e0e0
style Endoplasmic_Reticulum_Stress_R fill:#888,stroke:#4fc3f7,color:#e0e0e0
style Apoptosis fill:#888,stroke:#4fc3f7,color:#e0e0e0
style Cancer_Related_Signal_Transduc fill:#5d4400,stroke:#4fc3f7,color:#e0e0e0
style Atherosclerosis fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0
style GENES fill:#1b5e20,stroke:#4fc3f7,colo

MAPK3 Gene

Pathway Diagram

Introduction

Mitogen-Activated Protein Kinase 3 (MAPK3/ERK1) is a serine/threonine kinase that plays central roles in cellular proliferation, differentiation, survival, and synaptic plasticity. It is a key component of the MAPK/ERK signaling pathway, one of the most important intracellular signaling cascades in eukaryotic cells<sup>[1]</sup>. [@erk2015]

ERK1 was first identified as a kinase that becomes activated in response to growth factors and mitogens, triggering cellular responses ranging from gene expression to cell division. In the nervous system, ERK1 (along with its close relative ERK2) has emerged as a critical regulator of neuronal development, synaptic plasticity, learning and memory, and responses to neural injury. Dysregulation of ERK signaling has been strongly implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders<sup>[2]</sup>. [@erk2010]

--- [@mapk2018]

<div class="infobox infobox-gene"> [@erk2015a]
| | | [@mapk2018a]
|---|---| [@erk2019]
| Gene Symbol | MAPK3 | [@role2017]
| Full Name | Mitogen-Activated Protein Kinase 3 (ERK1) | [@antidepressant2016]
| Chromosomal Location | 16p11.2 |
| NCBI Gene ID | [5595](https://www.ncbi.nlm.nih.gov/gene/5595) |
| Ensembl ID | [ENSG00000102882](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000102882) |
| UniProt ID | [P27361](https://www.uniprot.org/uniprot/P27361) |
| Protein Length | 379 amino acids |
| Molecular Weight | 43 kDa |
| Protein Family | MAPK family, ERK1/2 subfamily |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Cancer, Depression, Stroke |
</div>

Overview

MAPK3 encodes ERK1, a 379-amino acid serine/threonine kinase that is a member of the MAPK family. The gene is located on chromosome 16p11.2 and is ubiquitously expressed, with particularly high levels in the brain. ERK1 is closely related to ERK2 (MAPK1), with both proteins sharing 83% sequence identity and largely overlapping functions<sup>[3]</sup>.

The MAPK/ERK cascade is one of the most studied signaling pathways in cell biology. It transduces extracellular signals from growth factors, hormones, and neurotransmitters to the nucleus, where it regulates gene expression programs controlling cell fate decisions. In neurons, this pathway is essential for [long-term potentiation](/mechanisms/long-term-potentiation) (LTP), long-term depression (LTD), and memory formation—processes that are disrupted in neurodegenerative diseases<sup>[4]</sup>.

Protein Structure

ERK1 contains several structurally and functionally important regions:

Kinase Domain (aa 1-350)

The catalytic domain contains:

• ATP-binding pocket: Located in the N-lobe
• Activation loop: Contains dual phosphorylation sites (T202, Y204)
• Substrate-binding groove: Recognizes consensus phosphorylation motif

Docking Grooves

ERK1 has two major docking sites:

• D-site: Basic region for binding D-motifs in substrates
• F-site: Hydrophobic pocket for F-motif interactions

Nuclear Localization Signals

ERK1 contains:

• Classical NLS sequences
• Exportin-dependent nuclear export signals

Molecular Function

MAPK/ERK Signaling Cascade

The canonical MAPK cascade proceeds as follows:

Dual Specificity

ERK1 is a dual-specificity kinase:

• Phosphorylates serine/threonine residues
• Autophosphorylates on tyrosine (Y204)
• Activated by MEK1/2-mediated phosphorylation

Nuclear Translocation

Upon activation:

• ERK1 translocates to the nucleus
• Phosphorylates transcription factors
• Regulates gene expression programs

Brain Expression and Function

Regional Expression

ERK1 is highly expressed in:

• [Hippocampus](/brain-regions/hippocampus): CA1-CA3 regions, dentate gyrus
• Cerebral [cortex](/brain-regions/cortex): All layers
• Cerebellum: Purkinje cells, granule cells
• Amygdala: Central and basal nuclei
• Basal ganglia: Striatum, substantia nigra

Cellular Distribution

In the brain, ERK1 is expressed in:

• [Neurons](/entities/neurons): Dendrites, [dendritic spines](/cell-types/dendritic-spines), nucleus
• [Astrocytes](/entities/astrocytes): Cytoplasmic localization
• [Microglia](/entities/microglia): Activation-dependent expression
• Oligodendrocytes: Myelination roles

Synaptic Function

ERK1 plays critical roles at synapses:

• Synaptic plasticity: Essential for [LTP](/mechanisms/long-term-potentiation) and LTD
• Dendritic spine morphology: Regulates spine size and density
• Local translation: Controls local protein synthesis
• [NMDA](/entities/nmda-receptor) receptor signaling: Modulates receptor function

Role in Neurodegeneration

Alzheimer's Disease

ERK1/2 activation is prominently altered in Alzheimer's disease:

Pathological Changes:

• Increased ERK1/2 phosphorylation in AD hippocampus
• Elevated activity in early disease stages
• Correlation with neurofibrillary tangle burden

• [Tau](/proteins/tau) phosphorylation: ERK1/2 phosphorylates tau at multiple sites
• Amyloid-β effects: [Aβ](/proteins/amyloid-beta) stimulates ERK1/2 activation
• Synaptic dysfunction: Abnormal ERK signaling impairs plasticity
• Gene expression dysregulation: Altered transcription programs<sup>[5]</sup>

• ERK pathway modulators as potential therapeutics
• Timing-dependent effects (early vs. late disease)
• Interaction with other signaling pathways

Parkinson's Disease

ERK signaling alterations in Parkinson's disease:

Dopaminergic Neuron Vulnerability:

• Altered ERK activation in substantia nigra
• LRRK2 mutations affect ERK pathway
• May influence neuronal survival

• α-Synuclein phosphorylation by ERK
• Toxicity modulation through ERK signaling
• PD therapeutic targeting

• BDNF-mediated neuroprotection via ERK
• Growth factor signaling benefits

Stroke and Ischemia

ERK1/2 has dual roles in stroke:

Acute Phase:

• Rapid activation in response to ischemia
• May contribute to excitotoxic cell death
• Inflammation-related signaling

• Promotes neuronal survival mechanisms
• Supports axonal sprouting
• Facilitates rehabilitation-dependent plasticity

Depression and Anxiety

ERK1/2 in mood disorders:

• Reduced ERK signaling in depression models
• Antidepressant effects via ERK activation
• Stress effects on ERK pathway

Interaction Network

ERK1 interacts with numerous proteins:

Upstream Activators

• Growth factor receptors (EGFR, TrkA, TrkB)
• G-protein coupled receptors
• Ion channels
• Integrins

Kinase Cascade Members

• RAS family (HRAS, KRAS, NRAS)
• RAF kinases (ARAF, BRAF, RAF1)
• MEK1/2 (MAP2K1, MAP2K2)

Transcription Factors

• ELK-1
• c-Fos
• c-Myc
• CREB

Synaptic Proteins

• NMDA receptor subunits
• AMPA receptor subunits
• PSD-95
• Synapsin

Disease-Related Proteins

• [APP](/entities/app-protein) and Aβ
• [Tau protein](/proteins/tau)
• α-Synuclein
• [LRRK2](/genes/lrrk2)

Therapeutic Implications

Small Molecule Modulators

ERK pathway modulators under development:

• MEK inhibitors: Upstream pathway blockade
• ERK inhibitors: Direct kinase inhibition
• Dual-specificity inhibitors: Target multiple kinases

Neuropsychiatric Applications

• Depression: ERK-activating compounds
• Memory enhancement: Strategic activation
• Stroke recovery: Timing-dependent modulation

Biomarker Potential

• CSF ERK1/2 phosphorylation as biomarker
• Peripheral blood mononuclear cell signaling
• Imaging agents for ERK pathway activity

Key Publications

See Also

• [MAPK3 Protein](/proteins/mapk3-protein)
• [MAPK1 Gene](/genes/mapk1)
• [MAPK Signaling](/mechanisms/mapk-signaling-neurodegeneration))
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)

External Links

• [NCBI Gene: MAPK3](https://www.ncbi.nlm.nih.gov/gene/5595)
• [UniProt: ERK1](https://www.uniprot.org/uniprot/P27361)
• [Human Protein Atlas: MAPK3](https://www.proteinatlas.org/ENSG00000102882-MAPK3)
• [PhosphoSitePlus: ERK1](https://www.phosphosite.org/proteinAction.action?id=3848)

Background

The study of MAPK3/ERK1 has a rich history in cell signaling research. Discovered in the 1980s as a major extracellular signal-responsive kinase, ERK1 has become one of the most extensively studied signaling proteins. In neuroscience, ERK1's role in synaptic plasticity and memory was recognized in the 1990s, and its dysregulation in neurodegenerative disease has been an intense area of research ever since.

Key historical milestones include:

• 1980s: Discovery of ERK as growth factor-responsive kinase
• 1992: Cloning of ERK1 (MAPK3)
• 1998: Recognition of ERK in synaptic plasticity
• 2000s: Links to neurodegenerative disease
• 2010s: Therapeutic targeting efforts

Brain Atlas Resources

Allen Brain Atlas Links

The Allen Brain Atlas provides comprehensive gene expression data across brain regions and cell types.

• [Allen Human Brain Atlas](https://human.brain-map.org/) — Gene expression data across the adult human brain
• [Allen Mouse Brain Atlas](https://mouse.brain-map.org/) — Gene expression in mouse brain
• [Allen Cell Type Atlas](https://celltype.brain-map.org/) — Single-cell transcriptomics data
• [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/) — Developmental expression data
• [Allen Brain Map Portal](https://portal.brain-map.org/) — Access to all Allen Institute brain data

Gene-Specific Expression Data

Search for expression data on the Allen Brain Atlas:

• [Human Brain Atlas search for this gene](https://human.brain-map.org/microarray/search/show?search_term=MAPK3)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving MAPK3 Gene - ERK1 discovered through SciDEX knowledge graph analysis: